Evidence map›Paper›PMID 40901933›Full record

ArticlePLoS computational biology2025

Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators.

Jordy Peeters, Dimitri De Bundel, Kenno Vanommeslaeghe

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Deciphering the allosteric landscape of 5-HTPharmacological reports : PR · 2026
    Article
  2. Decoding Prolonged Residence Time of 5-HTJournal of chemical information and modeling · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jordy PeetersDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Vrije Universiteit Brussel (VUB), Brussels, Belgium.ORCID 0000-0003-1604-4799
Dimitri De BundelExperimental Pharmacology (EFAR) group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Kenno VanommeslaegheDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Vrije Universiteit Brussel (VUB), Brussels, Belgium.ORCID 0000-0003-1786-5708

Funding

Vrije Universiteit Brussel (VUB)VSC (Flemish Supercomputer Center)
6 · The paper itself

Abstract

The serotonin-2A receptor (5-HT2AR) is an interesting target for drug design in the context of antidepressants that might have a rapid onset of action and/or be effective in treatment-resistant cases. The main challenge, however, is that the activation of this receptor can provoke hallucinations. Recent studies have shown that activating the receptor with certain (partial) agonists could potentially give rise to antidepressant effect without hallucinogenic side effects. Although substantial research has been done in this area, the atomistic details of this differential activation of the serotonin-2A receptor are not fully understood. In the present study we performed multiple atomistic molecular dynamics (MD) simulations on 5-HT2AR bound with two antipsychotics, three different potential non-hallucinogens and two hallucinogens to identify the receptor's ligand dependent conformations. Overall, our findings suggest that modest 5-HT2AR activation would only yield antidepressant effects and hallucinations result from excessive activation. While modest activation through microdosing may be problematic on account of abuse potential as well as possibly narrow and patient-dependent therapeutic windows, modest activation through administration of a sufficiently weak partial agonist may offer a viable drug development pathway.

Indexed as

Molecular Dynamics SimulationReceptor, Serotonin, 5-HT2AAntidepressive AgentsAntipsychotic AgentsHallucinogensHumansLigandsProtein BindingSerotonin 5-HT2 Receptor AgonistsAntidepressive AgentsAntipsychotic AgentsHallucinogensLigandsReceptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor Agonists

Identifiers

PMID40901933
PMCPMC12443254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.